Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$1.46 - $3.55 $4.34 Million - $10.5 Million
2,970,728 Added 270.07%
4,070,728 $8.59 Million
Q3 2021

Oct 27, 2021

BUY
$6.79 - $13.9 $1.36 Million - $2.78 Million
200,000 Added 22.22%
1,100,000 $7.74 Million
Q1 2021

May 03, 2021

BUY
$9.71 - $18.6 $8.74 Million - $16.7 Million
900,000 New
900,000 $9.63 Million

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track State Of Michigan Retirement System Portfolio

Follow State Of Michigan Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.